Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Terapie
    komórkami macierzystymi

    Terapie komórkami macierzystymi

    Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).

    Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.

    Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.

    Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.

    Data aktualizacji: 06.2026

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
    Lp. Źródło Typ źródła Wskazanie Obszar medycyny Rok podania Terapia Kraj Wiek odbiorcy
    7301 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 70
    7302 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 51
    7303 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 53
    7304 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 68
    7305 Apheresis Allogeneic Myelodysplastic Syndrome In Fanconi Anemia Hematology 2017 Standard Therapy Poland 23
    7306 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Of Blasts Hematology 2017 Standard Therapy Germany 62
    7307 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 63
    7308 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 63
    7309 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 66
    7310 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
    7311 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 55
    7312 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
    7313 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
    7314 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 72
    7315 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Germany 70
    7316 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2017 Standard Therapy Poland 47
    7317 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 44
    7318 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 56
    7319 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 57
    7320 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 38
    7321 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2017 Standard Therapy Poland 7
    7322 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2017 Standard Therapy Germany 37
    7323 Apheresis Allogeneic Niemann–Pick Disease Hematology 2017 Standard Therapy Poland 2
    7324 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 36
    7325 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 58
    7326 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 53
    7327 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 1
    7328 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 55
    7329 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 63
    7330 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 56
    7331 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 47
    7332 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 57
    7333 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 65
    7334 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 58
    7335 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 42
    7336 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 36
    7337 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 63
    7338 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 68
    7339 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 52
    7340 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 53
    7341 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 56
    7342 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 65
    7343 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 55
    7344 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 69
    7345 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 69
    7346 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 72
    7347 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 51
    7348 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 57
    7349 Apheresis Autologous Non-Hodgkin-Lymphoma-Relapse Hematology 2017 Standard Therapy Germany 52
    7350 Apheresis Allogeneic Osteopetrosis Metabolic 2017 Standard Therapy Poland 3
    7351 Apheresis Allogeneic Other Malignancy Hematology 2017 Standard Therapy Poland 59
    7352 Apheresis Allogeneic Other Myelofibrosis Hematology 2017 Standard Therapy Poland 71
    7353 Apheresis Allogeneic Post–Polycythemia Vera Myelofibrosis Hematology 2017 Standard Therapy Germany 61
    7354 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2017 Standard Therapy Germany 51
    7355 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2017 Standard Therapy Germany 66
    7356 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2017 Standard Therapy Germany 50
    7357 Apheresis Allogeneic Primary Immunodeficiency Hematology 2017 Standard Therapy Poland 4
    7358 Apheresis Allogeneic Primary Immunodeficiency Hematology 2017 Standard Therapy Poland 2
    7359 Apheresis Allogeneic Primary Myelofibrosis Hematology 2017 Standard Therapy Poland 29
    7360 Apheresis Allogeneic Primary Myelofibrosis Hematology 2017 Standard Therapy Poland 32
    7361 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2017 Standard Therapy Poland 38
    7362 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2017 Standard Therapy Poland 63
    7363 Apheresis Allogeneic Richter’s Transformation At Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Germany 60
    7364 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2017 Standard Therapy Poland 24
    7365 Apheresis Allogeneic Secondary Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 61
    7366 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 14
    7367 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 27
    7368 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 32
    7369 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 16
    7370 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 30
    7371 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 7
    7372 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 25
    7373 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 28
    7374 Apheresis Allogeneic T-Cell Lymphoblastic Leukemia Hematology 2017 Standard Therapy Germany 24
    7375 Apheresis Allogeneic T-Cell Lymphoblastic Lymphoma Hematology 2017 Standard Therapy Germany 19
    7376 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 56
    7377 Apheresis Autologous T-Cell-Lymphoma Hematology 2017 Standard Therapy Germany 63
    7378 Apheresis Allogeneic Β – Thalassemia Major Hematology 2017 Standard Therapy Poland 4
    7379 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2016 Experimental Therapy Poland 22
    7380 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2016 Experimental Therapy Poland 32
    7381 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2016 Experimental Therapy Poland 44
    7382 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 14
    7383 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 6
    7384 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 60
    7385 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 3
    7386 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy Neurology 2016 Experimental Therapy Poland 11
    7387 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy Neurology 2016 Experimental Therapy Poland 6
    7388 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy Neurology 2016 Experimental Therapy Poland 9
    7389 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy; Encephalopathy Neurology 2016 Experimental Therapy Poland 8
    7390 Cord Tissue Allogeneic – Unrelated Age-Related Macular Degeneration Ophthalmology 2016 Experimental Therapy Poland 86
    7391 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 44
    7392 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 60
    7393 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 32
    7394 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 53
    7395 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 59
    7396 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 33
    7397 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 37
    7398 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 39
    7399 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 63
    7400 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 54